Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6373475rdf:typepubmed:Citationlld:pubmed
pubmed-article:6373475lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:6373475lifeskim:mentionsumls-concept:C0040300lld:lifeskim
pubmed-article:6373475lifeskim:mentionsumls-concept:C0007082lld:lifeskim
pubmed-article:6373475lifeskim:mentionsumls-concept:C0024623lld:lifeskim
pubmed-article:6373475lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:6373475lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:6373475pubmed:issue3lld:pubmed
pubmed-article:6373475pubmed:dateCreated1984-7-20lld:pubmed
pubmed-article:6373475pubmed:abstractTextGastric cancer specimens obtained from 162 patients who had undergone radical surgery with the routine postoperative administration of both mitomycin C and 5-fluorouracil were stained for carcinoembryonic antigen (CEA) by the unlabeled antibody enzyme technique. The CEA (-/+) group (92 cases) consisting of the negative and weakly positive staining cases had a significantly better survival rate over a period of 5 years than the CEA (++) group (70 cases) which comprised only strongly positive cases. The CEA (-/+) group with differentiated adenocarcinoma had the best prognosis and the 5-year survival rate was significantly higher than those of the other three groups. Among stage II and III carcinomas, the postoperative survival rate was significantly better in the CEA (-/+) group than in the CEA (++) group. Among the patients with lymph node metastasis, the postoperative survival rate was low, especially in the CEA (++) group. The present data suggest that staining for CEA in tissue sections of stomach carcinoma may be helpful in differentiating among tumors that appear similar by conventional histological methods, thus providing a new means for obtaining more precise prognostic information.lld:pubmed
pubmed-article:6373475pubmed:languageenglld:pubmed
pubmed-article:6373475pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6373475pubmed:citationSubsetIMlld:pubmed
pubmed-article:6373475pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6373475pubmed:statusMEDLINElld:pubmed
pubmed-article:6373475pubmed:monthMarlld:pubmed
pubmed-article:6373475pubmed:issn0016-450Xlld:pubmed
pubmed-article:6373475pubmed:authorpubmed-author:UeharaYYlld:pubmed
pubmed-article:6373475pubmed:authorpubmed-author:FujitaYYlld:pubmed
pubmed-article:6373475pubmed:authorpubmed-author:MajimaSSlld:pubmed
pubmed-article:6373475pubmed:authorpubmed-author:MajimaTTlld:pubmed
pubmed-article:6373475pubmed:authorpubmed-author:IkedaEElld:pubmed
pubmed-article:6373475pubmed:authorpubmed-author:KojimaOOlld:pubmed
pubmed-article:6373475pubmed:issnTypePrintlld:pubmed
pubmed-article:6373475pubmed:volume75lld:pubmed
pubmed-article:6373475pubmed:ownerNLMlld:pubmed
pubmed-article:6373475pubmed:authorsCompleteYlld:pubmed
pubmed-article:6373475pubmed:pagination230-6lld:pubmed
pubmed-article:6373475pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6373475pubmed:meshHeadingpubmed-meshheading:6373475-...lld:pubmed
pubmed-article:6373475pubmed:meshHeadingpubmed-meshheading:6373475-...lld:pubmed
pubmed-article:6373475pubmed:meshHeadingpubmed-meshheading:6373475-...lld:pubmed
pubmed-article:6373475pubmed:meshHeadingpubmed-meshheading:6373475-...lld:pubmed
pubmed-article:6373475pubmed:meshHeadingpubmed-meshheading:6373475-...lld:pubmed
pubmed-article:6373475pubmed:meshHeadingpubmed-meshheading:6373475-...lld:pubmed
pubmed-article:6373475pubmed:year1984lld:pubmed
pubmed-article:6373475pubmed:articleTitleCorrelation between carcinoembryonic antigen in gastric cancer tissue and survival of patients with gastric cancer.lld:pubmed
pubmed-article:6373475pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6373475pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6373475lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6373475lld:pubmed